The use of covalently immobilized stem cell factor to selectively affect hematopoietic stem cell activity within a gelatin hydrogel

Biomaterials

Volumn 67, Issue , 2015, Pages 297-307

  Mahadik, Bhushan P ^a   Pedron Haba, Sara ^a   Skertich, Luke J ^a   Harley, Brendan A C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Bone marrow; Cell activation; Growth factor; Hydrogel; Stem cell

Indexed keywords

BIOACTIVITY; BONE; CELL CULTURE; CELL PROLIFERATION; CELLS; CYTOLOGY; HYDROGELS;

BIOMOLECULAR SIGNALS; BONE MARROW; CELL ACTIVATION; CELL CULTURE MEDIA; CRITICAL COMPONENT; GROWTH FACTOR; HEMATOPOIETIC STEM CELLS; LINEAGE SPECIFICATION;

STEM CELLS;

ACRYLIC ACID; BIOMATERIAL; GELATIN; MACROGOL; MEMBRANE ANTIGEN; METHACRYLAMIDE FUNCTIONALIZED GELATIN; STEM CELL FACTOR; UNCLASSIFIED DRUG; ACRYLAMIDE DERIVATIVE; HYDROGEL; IMMOBILIZED PROTEIN; MACROGOL DERIVATIVE; METHACRYLAMIDE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; ENCAPSULATION; FEMALE; HEMATOPOIETIC STEM CELL; HYDROGEL; IMMOBILIZED CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PHOTOCHEMISTRY; PRIORITY JOURNAL; STEM CELL EXPANSION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; MICROFLUIDICS; PHARMACOLOGY; PIG;

MURINAE;

ACRYLAMIDES; ANIMALS; CELL DIFFERENTIATION; CELL SURVIVAL; FEMALE; GELATIN; HEMATOPOIETIC STEM CELLS; HYDROGEL; IMMOBILIZED PROTEINS; MICE, INBRED C57BL; MICROFLUIDICS; POLYETHYLENE GLYCOLS; STEM CELL FACTOR; SUS SCROFA;

EID: 84939634318     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.07.042     Document Type: Article

References (82)

1. Thomas E.D., Lochte H.L., Lu W.C., Ferrebee J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 1957, 257:491-496.
2. Liang Y., Van Zant G., Szilvassy S.J. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 2005, 106:1479-1487.
3. Nichols J.E., Niles J., Walls S., Cortiella J. In vitro human bone marrow analog: clinical potential. Regen. Med. 2010, 5:289-298.
4. Wolff S.N. Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation. Bone Marrow Transpl. 2002, 29:545-552.
5. Hines M., Nielsen L., Cooper-White J. The hematopoietic stem cell niche: what are we trying to replicate?. J. Chem. Technol. Biotechnol. 2008, 83:421-443.
6. Wilson A., Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 2006, 6:93-106.
7. Tokoyoda K., Egawa T., Sugiyama T., Choi B.I., Nagasawa T. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 2004, 20:707-718.
8. Oh I.H., Humphries R.K. Concise review: multidimensional regulation of the hematopoietic stem cell state. Stem Cells 2012, 30:82-88.
9. Smith J.N., Calvi L.M. Concise review: current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells. Stem Cells 2013, 31:1044-1050.
10. Isern J., Mendez-Ferrer S. Stem cell interactions in a bone marrow niche. Curr. Osteoporos. Rep. 2011, 9:210-218.
11. Ehninger A., Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J. Exp. Med. 2011, 208:421-428.
12. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
13. Hosokawa K., Arai F., Yoshihara H., Iwasaki H., Nakamura Y., Gomei Y., et al. Knockdown of N-cadherin suppresses the long-term engraftment of hematopoietic stem cells. Blood 2010, 116:554-563.
14. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
15. Ding L., Saunders T.L., Enikolopov G., Morrison S.J. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012, 481:457-462.
16. Chow A., Lucas D., Hidalgo A., Méndez-Ferrer S., Hashimoto D., Scheiermann C., et al. Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J. Exp. Med. 2011, 208:261-271.
17. Omatsu Y., Sugiyama T., Kohara H., Kondoh G., Fujii N., Kohno K., et al. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity 2010, 33:387-399.
18. Nie Y., Han Y.C., Zou Y.R. CXCR4 is required for the quiescence of primitive hematopoietic cells. J. Exp. Med. 2008, 205:777-783.
19. Park S.-Y., Wolfram P., Canty K., Harley B.A., Nombela Arrieta C., Pivarnik G., et al. Focal adhesion kinase regulates the localization and retention of pro-B cells in bone marrow microenvironments. J. Immunol. 2013, 190:1094-1102.
20. Glodek A.M., Le Y., Dykxhoorn D.M., Park S.Y., Mostoslavsky G., Mulligan R., et al. Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells. Leukemia 2007, 21(8):1723-1732.
21. Kaplan R.N., Psaila B., Lyden D. Niche-to-niche migration of bone-marrow-derived cells. Trends Mol. Med. 2007, 13:72-81.
22. Tabe Y., Jin L., Tsutsumi-Ishii Y., Xu Y., McQueen T., Priebe W., et al. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res. 2007, 67:684-694.
23. Tavernier-Tardy E., Cornillon J., Campos L., Flandrin P., Duval A., Nadal N., et al. Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia. Leuk. Res. 2009, 33:764-768.
24. Liaw T.Y., Salam N.K., McKay M.J., Cunningham A.M., Hibbs D.E., Kavallaris M. Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions. Mol. Cancer Ther. 2008, 7:3150-3159.
25. Zhou K., Huang L., Zhou Z., Hu C., Liu W., Zhou J., et al. Wnt and Notch signaling pathways selectively regulating hematopoiesis. Ann. Hematol. 2010, 89:749-757.
26. Kucia M., Ratajczak J., Ratajczak M.Z. Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells. Biol. Cell 2005, 97:133-146.
27. Tzeng Y.S., Li H., Kang Y.L., Chen W.C., Cheng W.C., Lai D.M. Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression. Blood 2011, 117:429-439.
28. Teicher B.A., Fricker S.P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clinical cancer research. Off. J. Am. Assoc. Cancer Res. 2010, 16:2927-2931.
29. Shin J.W., Buxboim A., Spinler K.R., Swift J., Christian D.A., Hunter C.A., et al. Contractile forces sustain and polarize hematopoiesis from stem and progenitor cells. Cell Stem Cell 2014, 14:81-93.
30. Choi J.-S., Harley B.A. The combined influence of substrate elasticity and ligand density on the viability and biophysical properties of hematopoietic stem and progenitor cells. Biomaterials 2012, 33:4460-4468.
31. Shin J.W., Swift J., Ivanovska I., Spinler K.R., Buxboim A., Discher D.E. Mechanobiology of bone marrow stem cells: from myosin-II forces to compliance of matrix and nucleus in cell forms and fates. Differentiation 2013, 86:77-86.
32. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
33. Lutolf M.P., Doyonnas R., Havenstrite K., Koleckar K., Blau H.M. Perturbation of single hematopoietic stem cell fates in artificial niches. Integr. Biol. (Camb) 2009, 1:59-69.
34. Mahadik B.P., Wheeler T.D., Skertich L.J., Kenis P.J.A., Harley B.A.C. Microfluidic generation of gradient hydrogels to modulate hematopoietic stem cell culture environment. Adv. Healthc. Mater. 2014, 3:449-458.
35. Kurth I., Franke K., Pompe T., Bornhauser M., Werner C. Hematopoietic stem and progenitor cells in adhesive microcavities. Integr. Biol. (Camb) 2009, 1:427-434.
36. Kobel S., Limacher M., Gobaa S., Laroche T., Lutolf M.P. Micropatterning of hydrogels by soft embossing. Langmuir 2009, 25:8774-8779.
37. Calderon L., Boehm T. Synergistic, context-dependent, and hierarchical functions of epithelial components in thymic microenvironments. Cell 2012, 149:159-172.
38. Doran M.R., Markway B.D., Aird I.A., Rowlands A.S., George P.A., Nielsen L.K., et al. Surface-bound stem cell factor and the promotion of hematopoietic cell expansion. Biomaterials 2009, 30:4047-4052.
39. Driessen R.L., Johnston H.M., Nilsson S.K. Membrane-bound stem cell factor is a key regulator in the initial lodgment of stem cells within the endosteal marrow region. Exp. Hematol. 2003, 31:1284-1291.
40. Kishimoto S., Nakamura S., Hattori H., Oonuma F., Kanatani Y., Tanaka Y., et al. Human stem cell factor (SCF) is a heparin-binding cytokine. J. Biochem. 2009, 145:275-278.
41. Kishimoto S., Nakamura S., Hattori H., Oonuma F., Kanatani Y., Tanaka Y., et al. Cytokine-immobilized microparticle-coated plates for culturing hematopoietic progenitor cells. Journal of controlled release. Off. J. Control. Release Soc. 2009, 133:185-190.
42. Cuchiara M.L., Horter K.L., Banda O.A., West J.L. Covalent immobilization of stem cell factor and stromal derived factor 1alpha for in vitro culture of hematopoietic progenitor cells. Acta Biomater. 2013, 9:9258-9269.
43. Martin T.A., Caliari S.R., Williford P.D., Harley B.A., Bailey R.C. The generation of biomolecular patterns in highly porous collagen-GAG scaffolds using direct photolithography. Biomaterials 2011, 32:3949-3957.
44. DeForest C.A., Polizzotti B.D., Anseth K.S. Sequential click reactions for synthesizing and patterning three-dimensional cell microenvironments. Nat. Mater. 2009, 8:659-664.
45. Sridhar B.V., Doyle N.R., Randolph M.A., Anseth K.S. Covalently tethered TGF-beta1 with encapsulated chondrocytes in a PEG hydrogel system enhances extracellular matrix production. J. Biomed. Mater. Res. A 2014, 102:4464-4472.
46. Nilsson S.K., Debatis M.E., Dooner M.S., Madri J.A., Quesenberry P.J., Becker P.S. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J. Histochem. Cytochem. 1998, 46:371-377.
47. Jansen L.E., Birch N.P., Schiffman J.D., Crosby A.J., Peyton S.R. Mechanics of intact bone marrow. J. Mech. Behav. Biomed. Mater. 2015, 50:299-307.
48. Nombela-Arrieta C., Pivarnik G., Winkel B., Canty K.J., Harley B., Mahoney J.E., et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat. Cell Biol. 2013, 15:533-543.
49. Cosson S., Lutolf M.P. Hydrogel microfluidics for the patterning of pluripotent stem cells. Sci. Rep. 2014, 4:4462.
50. Kothapalli C.R., van Veen E., de Valence S., Chung S., Zervantonakis I.K., Gertler F.B., et al. A high-throughput microfluidic assay to study neurite response to growth factor gradients. Lab. Chip 2011, 11:497-507.
51. Fosser K.A., Nuzzo R.G. Fabrication of patterned multicomponent protein gradients and gradient arrays using microfluidic depletion. Anal. Chem. 2003, 75:5775-5782.
52. Hutson C.B., Nichol J.W., Aubin H., Bae H., Yamanlar S., Al-Haque S., et al. Synthesis and characterization of tunable poly(ethylene glycol): gelatin methacrylate composite hydrogels. Tissue Eng. Part A 2011, 17:1713-1723.
53. Gorgieva S., Kokol V. Preparation, characterization, and in vitro enzymatic degradation of chitosan-gelatine hydrogel scaffolds as potential biomaterials. J. Biomed. Mater. Res. A 2012, 100:1655-1667.
54. Pedron S., Harley B.A.C. The impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy. J. Biomed. Mater. Res. Pt A 2013, 101:3405-3415.
55. Brinkman W.T., Nagapudi K., Thomas B.S., Chaikof E.L. Photo-cross-linking of type I collagen gels in the presence of smooth muscle cells: mechanical properties, cell viability, and function. Biomacromolecules 2003, 4:890-895.
56. Fairbanks B.D., Schwartz M.P., Bowman C.N., Anseth K.S. Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility. Biomaterials 2009, 30:6702-6707.
57. DeLong S.A., Moon J.J., West J.L. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 2005, 26:3227-3234.
58. Leisten I., Kramann R., Ventura Ferreira M.S., Bovi M., Neuss S., Ziegler P., et al. 3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche. Biomaterials 2012, 33:1736-1747.
59. Liao J., Hammerick K.E., Challen G.A., Goodell M.A., Kasper F.K., Mikos A.G. Investigating the role of hematopoietic stem and progenitor cells in regulating the osteogenic differentiation of mesenchymal stem cells in vitro. J. Orthop. Res. 2011, 29:1544-1553.
60. Gabrielson N.P., Desai A.V., Mahadik B., Hofmann M.C., Kenis P.J., Harley B.A. Cell-laden hydrogels in integrated microfluidic devices for long-term cell culture and tubulogenesis assays. Small 2013, 9:3076-3081.
61. Pedron S., Becka E., Harley B.A.C. Spatially-gradated hydrogel platform as a three-dimensional engineered tumor microenvironment. Adv. Mater. 2015, 27:1567-1572.
62. Haylock D.N., Nilsson S.K. Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle 2005, 4:1353-1355.
63. Morrison S.J., Scadden D.T. The bone marrow niche for haematopoietic stem cells. Nature 2014, 505:327-334.
64. Scadden D.T. The stem-cell niche as an entity of action. Nature 2006, 441:1075-1079.
65. Gammaitoni L., Bruno S., Sanavio F., Gunetti M., Kollet O., Cavalloni G., et al. Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp. Hematol. 2003, 31:261-270.
66. Zhang C.C., Lodish H.F. Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion. Blood 2005, 105:4314-4320.
67. Alberti K., Davey R.E., Onishi K., George S., Salchert K., Seib F.P., et al. Functional immobilization of signaling proteins enables control of stem cell fate. Nat. Methods 2008, 5:645-650.
68. Panuganti S., Schlinker A.C., Lindholm P.F., Papoutsakis E.T., Miller W.M. Three-stage ex vivo expansion of high-ploidy megakaryocytic cells: toward large-scale platelet production. Tissue Eng. Part A 2013, 19:998-1014.
69. Pedron S., Becka E., Harley B.A. Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid. Biomaterials 2013, 34:7408-7417.
70. Fedorovich N.E., Oudshoorn M.H., van Geemen D., Hennink W.E., Alblas J., Dhert W.J.A. The effect of photopolymerization on stem cells embedded in hydrogels. Biomaterials 2009, 30:344-353.
71. Gandavarapu N.R., Azagarsamy M.A., Anseth K.S. Photo-click living strategy for controlled, reversible exchange of biochemical ligands. Adv. Mater. 2014, 26:2521-2526.
72. Aimetti A.A., Machen A.J., Anseth K.S. Poly(ethylene glycol) hydrogels formed by thiol-ene photopolymerization for enzyme-responsive protein delivery. Biomaterials 2009, 30:6048-6054.
73. Caliari S.R., Harley B.A. Composite growth factor supplementation strategies to enhance tenocyte bioactivity in aligned collagen-GAG scaffolds. Tissue Eng. Part A 2013, 19:1100-1112.
74. Sahoo S., Toh S.L., Goh J.C. A bFGF-releasing silk/PLGA-based biohybrid scaffold for ligament/tendon tissue engineering using mesenchymal progenitor cells. Biomaterials 2010, 31:2990-2998.
75. Pineault N., Cortin V., Boyer L., Garnier A., Robert A., Therien C., et al. Individual and synergistic cytokine effects controlling the expansion of cord blood CD34(+) cells and megakaryocyte progenitors in culture. Cytotherapy 2011, 13:467-480.
76. Zandstra P.W., Jervis E., Haynes C.A., Kilburn D.G., Eaves C.J., Piret J.M. Concentration-dependent internalization of a cytokine/cytokine receptor complex in human hematopoietic cells. Biotechnol. Bioeng. 1999, 63:493-501.
77. Shimizu Y., Ashman L.K., Du Z., Schwartz L.B. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit. J. Immunol. 1996, 156:3443-3449.
78. Anderson S.M., Shergill B., Barry Z.T., Manousiouthakis E., Chen T.T., Botvinick E., et al. VEGF internalization is not required for VEGFR-2 phosphorylation in bioengineered surfaces with covalently linked VEGF. Integr. Biol. (Camb) 2011, 3:887-896.
79. Kobel S., Lutolf M. High-throughput methods to define complex stem cell niches. Biotechniques 2010, 48. ix-xxii.
80. Aguado B.A., Mulyasasmita W., Su J., Lampe K.J., Heilshorn S.C. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng. Part A 2012, 18:806-815.
81. Zhang C.C., Kaba M., Ge G., Xie K., Tong W., Hug C., et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat. Med. 2006, 12:240-245.
82. Hofmeister C.C., Zhang J., Knight K.L., Le P., Stiff P.J. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transpl. 2007, 39:11-23.